Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date Extracellular Vesicles: From Waste EVictees to Therapeutic Reality Amy Kauffman, PhD Once thought to be merely evictees of cell debris, extracellular vesicles (EVs) hold the promise of the next generation therapeutic agent. EVs are kno... 2 months ago | 31 mins Assessing the Risk of Interaction Between Extractables and Leachable and Ther... Andrew Teasdale, Senior Principal Scientist at AstraZeneca and Piet Christieans, Phd,Scientific Director at Nelson Labs FULL TITLE: Assessing the Risk of Interaction Between Extractables and Leachable and Therapeutic Proteins Presented by Andrew Teasdale, Senior Princ... 3 years ago | 94 mins Developability Assessment of Therapeutic Proteins – A Toolbox for Tackling Incre Thorsten Lorenz, Team Head Developability Assessment Biologics, Novartis and Beate Kern, Product Manager, NanoTemper Title: Developability Assessment of Therapeutic Proteins – A Toolbox for Tackling Increasing Complexity Presenter: Thorsten Lorenz, Team Head Developa... 5 years ago | 65 mins Effect of Cell Culture Process Change from Fed-batch to Continuous on... Ru Zang, Associate Director at Mersana Therapeutics and John Bonham Carter,Project Line Lead at Repligen EFFECT OF CELL CULTURE PROCESS CHANGE FROM FED-BATCH TO CONTINUOUS ON PRODUCTIVITY AND PRODUCT QUALITY Integrated continuous bioprocessing has attrac... 4 years ago | 76 mins Establish Early Development Strategies For Therapeutics Proteins Sorina Morar-Mitrica, Principal Fellow at Novartis and Bernardo Cordovez, PhD, Chief Science Officer & Founder, Halo Labs Presented by Sorina Morar-Mitrica, Principal Fellow Sr Drug Product Lead Early Phase Biologics at Novartis The protein therapeutics field has expande... 2 years ago | 92 mins Next Frontier in Subvisible Particle Analysis: New Tools and Opportunities Danny Chou, President and Founder at Compassion BioSolution, and Mark Mark Bumiller, Technology Manager at Entegris. Presented by Danny Chou, President and Founder at Compassion BioSolution, LLC Followed by an industry perspective presented by Mark Bumiller, Technolo... 3 years ago | 100 mins Application of Next Generation Sequencing (NGS) Based Methods... Jurgen Mulberg Associate Director at Bristol Myers Squibb and Joanna Zmurko, NGS specialist at PathoQuest Full Title: Application of Next Generation Sequencing (NGS) Based Methods for Detection of Viral Contaminants in Biomanufacturing Contamination of a ... 1 year ago | 90 mins Considerations on Impact of Raw Material Variability in Gene Therapy Aaron Mack,Greg Stromberg and Dr Lisa Dixon Full title: CONSIDERATIONS ON IMPACT OF RAW MATERIAL VARIABILITY IN GENE THERAPY MANUFACTURING: APPLYING LESSONS LEARNED FROM BIOLOGIC'S MANUFACTURING... 2 years ago | 83 mins Novel applications for Ex-vivo PDX models of the Tumor Microenvironment Veronica Sacchi, PhD, Scientist III, PhenoVista Biosciences Ex-vivo platforms are useful to gain data regarding the efficacy of an oncology treatment throughout the course and after completion of a study. Furth... 3 years ago | 38 mins Single-Use & Stainless Steel BioReactors: Quality Factors for Consideration Dr Trevor Deeks, Principal and Consultant of Deeks Pharmaceutical Consulting Services, LLC Single-use (SU) systems are now in common use in pharmaceutical bioprocessing, as well as in other related technologies such as the manufacture of dia... 5 years ago | 76 mins
